サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1592660

欧州のボツリヌス毒素市場：2031年までの予測 - 地域別分析 - 製品別、用途別、エンドユーザー別

Europe Botulinum Toxin Market Forecast to 2031 - Regional Analysis - by Product (Botulinum Toxin A and Botulinum Toxin B), Application (Medical and Aesthetic), and End User (Specialty & Dermatology Clinics, Hospitals & Clinics, and Others)

出版日
ページ情報
英文 75 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円
欧州のボツリヌス毒素市場：2031年までの予測 - 地域別分析 - 製品別、用途別、エンドユーザー別
出版日: 2024年09月16日
発行: The Insight Partners
ページ情報: 英文 75 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州のボツリヌス毒素市場は、2023年に11億7,494万米ドルとなり、2031年までには29億3,174万米ドルに達すると予測され、2023年から2031年にかけて12.1%のCAGRを記録すると推定されています。

欧州の高齢化が欧州のボツリヌス毒素市場を牽引

欧州の高齢化は市場成長の大きな機会です。同地域の人口動態が高齢化へとシフトするにつれ、ボトックスなどのアンチエイジング治療に対する需要も並行して増加しています。高齢者が若々しい外見を維持するために非侵襲的な解決策を求める中、皮膚充填剤の需要が増加しています。2023年1月1日現在、欧州連合（EU）の推定人口は4億4,880万人で、人口のほぼ5分の1（21.3％）が65歳以上です。EUの人口中央値は2023年1月1日に44.5歳に達しました。より長持ちし、自然な仕上がりを提供するフィラー技術の進歩は、この層の選好に応え、市場拡大をさらに促進しています。

欧州のボツリヌス毒素市場の概要

欧州のボツリヌス毒素市場は、ドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。欧州は世界のボツリヌス毒素市場で重要な位置を占めており、予測期間中に力強い成長率を記録すると予想されています。同地域の市場成長は主に、ボツリヌス毒素企業による製品開拓と、ドイツ、英国、フランス、イタリアなどの欧州諸国におけるあらゆる年齢層の人々の現代的な美容基準に対する意識の高まりに起因しています。さらに、ヘルスケアシステムの進歩は、今後数年間、この地域全体のボツリヌス毒素の需要を促進する可能性が高いです。ドイツのヘルスケア部門は、美容や医療処置に先進技術を活用しています。ISAPSによると、2021年には、30万6,296のボツリヌス毒素治療を含む合計60万5,942の非外科的美容処置が国内で実施されました。このように、ドイツにおけるボツリヌス毒素市場は、非外科的美容施術の件数の増加、低侵襲施術の認知度の向上により、成長が見込まれています。また、各社は国内での直接注文や顧客配達のために製品を発売しています。2023年2月、Evolus, Inc.はNuceivaをドイツで商業的に発売し、直接注文と顧客への配達を開始しました。

欧州のボツリヌス毒素市場の収益と2031年までの予測（百万米ドル）

欧州のボツリヌス毒素市場のセグメンテーション

欧州のボツリヌス毒素市場は、製品、用途、エンドユーザー、国に分類されます。

製品別では、欧州のボツリヌス毒素市場はボツリヌス毒素Aとボツリヌス毒素Bに二分されます。2023年の欧州のボツリヌス毒素市場シェアでは、ボツリヌス毒素Aセグメントが大きなシェアを占めています。

用途別では、欧州のボツリヌス毒素市場は医療と美容に二分されます。2023年の欧州のボツリヌス毒素市場では、医療セグメントがより大きなシェアを占めました。さらに、医療セグメントは、慢性片頭痛、筋痙攣、過剰反応性膀胱、多汗症、その他に細分化されます。さらに、美容セグメントは、しかめ面ライン/グラベラー、額ライン、カラスの足跡、四角い顎/咬筋、その他に細分化されます。

エンドユーザー別では、欧州のボツリヌス毒素市場は専門・皮膚科クリニック、病院・クリニック、その他に分けられます。2023年の欧州のボツリヌス毒素市場では、専門・皮膚科クリニックセグメントが最大シェアを占めています。

国別では、欧州のボツリヌス毒素市場はドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。2023年の欧州のボツリヌス毒素市場シェアはドイツが独占しました。

Merz Pharma GmbH &Co KGaA、AbbVie Inc、Ipsen SA、Evolus Inc、Medytox Inc、Galderma SAは、欧州のボツリヌス毒素市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州のボツリヌス毒素市場：主要市場力学

  • 市場促進要因
    • 非侵襲的美容施術の人気上昇
    • 顔面美容のためのボツリヌス毒素使用の増加
  • 市場抑制要因
    • ボツリヌス毒素の副作用
  • 市場機会
    • 人口の高齢化
  • 今後の動向
    • 治療用途の拡大
  • 促進要因と抑制要因の影響

第5章 ボツリヌス毒素市場：欧州分析

  • ボツリヌス毒素市場の収益、2021年～2031年

第6章 欧州のボツリヌス毒素市場分析：製品別

  • ボツリヌス毒素A
  • ボツリヌス毒素B

第7章 欧州のボツリヌス毒素市場分析：用途別

  • 医療
  • 美容

第8章 欧州のボツリヌス毒素市場分析：エンドユーザー別

  • 専門クリニック・皮膚科クリニック
  • 病院・クリニック
  • その他

第9章 欧州のボツリヌス毒素市場：国別分析

  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州

第10章 企業プロファイル

  • Merz Pharma GmbH & Co KGaA
  • AbbVie Inc
  • Ipsen SA
  • Evolus Inc
  • Medytox Inc
  • Galderma SA

第11章 付録

図表

List Of Tables

  • Table 1. Botulinum Toxin Market Segmentation
  • Table 2. Europe Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 3. Europe Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 4. Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 5. Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 6. Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 7. Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 8. Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 9. United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 10. United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 11. United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 12. United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 13. United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 14. France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 15. France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 16. France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 17. France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 18. France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 19. Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 20. Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 21. Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 22. Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 23. Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 24. Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 25. Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 26. Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 27. Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 28. Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 29. Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 30. Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 31. Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Medical
  • Table 32. Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by Aesthetic
  • Table 33. Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 34. Glossary of Terms

List Of Figures

  • Figure 1. Botulinum Toxin Market Segmentation, by Country
  • Figure 2. Botulinum Toxin Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Botulinum Toxin Market Revenue (US$ Million), 2021-2031
  • Figure 5. Botulinum Toxin Market Share (%) - by Product (2023 and 2031)
  • Figure 6. Botulinum Toxin A: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Botulinum Toxin B: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Botulinum Toxin Market Share (%) - by Application (2023 and 2031)
  • Figure 9. Medical: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Aesthetic: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Botulinum Toxin Market Share (%) - by End User (2023 and 2031)
  • Figure 12. Specialty and Dermatology Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Hospitals and Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Others: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Europe: Botulinum Toxin Market, by Key Country - Revenue (2023) (US$ Million)
  • Figure 16. Europe: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 17. Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
目次
Product Code: TIPRE00026638

The Europe botulinum toxin market was valued at US$ 1,174.94 million in 2023 and is expected to reach US$ 2,931.74 million by 2031; it is estimated to register a CAGR of 12.1% from 2023 to 2031 .

Aging Population in Europe Drives Europe Botulinum Toxin Market

The aging population in Europe presents a significant opportunity for market growth. As the region's demographic landscape shifts towards an older population, there is a parallel increase in demand for anti-aging treatments, such as botox. With older individuals seeking non-invasive solutions to maintain a youthful appearance, the demand for dermal fillers is increasing. As of January 1, 2023, the estimated population of the European Union was 448.8 million, with almost one-fifth (21.3%) of the population being 65 years of age or older. The EU's population reached a median age of 44.5 years on January 1, 2023. Advancements in filler technology that offer longer-lasting results and natural-looking outcomes cater to the preference of this demographic, further driving market expansion.

Europe Botulinum Toxin Market Overview

The Europe botulinum toxin market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the global botulinum toxin market, and it is expected to record a strong growth rate during the forecast period. The market growth in the region is mainly attributed to product developments by botulinum toxin companies and an upsurge in the awareness of modern beauty standards among people from all age groups in European countries such as Germany, the UK, France, and Italy. In addition, advancements in healthcare systems are likely to propel the demand for botulinum toxin across the region in the coming years. The German healthcare sector utilizes advanced technologies in aesthetic and medical procedures. According to the ISAPS, a total of 605,942 nonsurgical aesthetic procedures were performed in the country in 2021, including 306,296 botulinum toxin treatments. Thus, the botulinum toxin market in Germany is expected to grow with the rising number of nonsurgical cosmetic procedures, and the growing awareness of minimally invasive procedures. Also, companies are launching products in the country for direct orders and customer delivery. In February 2023, Evolus, Inc. commercially launched Nuceiva in Germany for direct orders and delivery to customers.

Europe Botulinum Toxin Market Revenue and Forecast to 2031 (US$ Million)

Europe Botulinum Toxin Market Segmentation

The Europe botulinum toxin market is categorized into product, application, end user, and country.

Based on product, the Europe botulinum toxin market is bifurcated into botulinum toxin A and botulinum toxin B. The botulinum toxin A segment held a larger share of Europe botulinum toxin market share in 2023.

In terms of application, the Europe botulinum toxin market is bifurcated into medical and aesthetic. The medical segment held a larger share of Europe botulinum toxin market in 2023. Furthermore, the medical segment is subcategorized into chronic migraine, muscle spasm, over reactive bladder, hyperhidrosis, and others. Additionally, the aesthetic segment is subcategorized into frown lines/ glabellar, forehead lines, crow's feet, square jaw/ masseter, and others.

By end user, the Europe botulinum toxin market is divided into specialty & dermatology clinics, hospitals & clinics, and others. The specialty and dermatology clinics segment held the largest share of Europe botulinum toxin market in 2023.

Based on country, the Europe botulinum toxin market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe botulinum toxin market share in 2023.

Merz Pharma GmbH & Co KGaA, AbbVie Inc, Ipsen SA, Evolus Inc, Medytox Inc, and Galderma SA are some of the leading companies operating in the Europe botulinum toxin market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Botulinum Toxin Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Popularity of Noninvasive Aesthetics Procedures
    • 4.1.2 Increasing Use of Botulinum Toxin for Enhancing Facial Aesthetics
  • 4.2 Market Restraints
    • 4.2.1 Side Effects of Botulinum Toxin
  • 4.3 Market Opportunities
    • 4.3.1 Aging Population
  • 4.4 Future Trends
    • 4.4.1 Expanding Therapeutic Applications
  • 4.5 Impact of Drivers and Restraints:

5. Botulinum Toxin Market - Europe Analysis

  • 5.1 Overview
  • 5.2 Botulinum Toxin Market Revenue (US$ Million), 2021-2031

6. Europe Botulinum Toxin Market Analysis - by Product

  • 6.1 Overview
  • 6.2 Botulinum Toxin A
    • 6.2.1 Overview
    • 6.2.2 Botulinum Toxin A: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Botulinum Toxin B
    • 6.3.1 Overview
    • 6.3.2 Botulinum Toxin B: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Botulinum Toxin Market Analysis - by Application

  • 7.1 Overview
  • 7.2 Medical
    • 7.2.1 Overview
    • 7.2.2 Medical: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
      • 7.2.2.1 Europe Botulinum Toxin Market Breakdown, by Medical
  • 7.3 Aesthetic
    • 7.3.1 Overview
    • 7.3.2 Aesthetic: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
      • 7.3.2.1 Europe Botulinum Toxin Market Breakdown, by Aesthetic

8. Europe Botulinum Toxin Market Analysis - by End User

  • 8.1 Overview
  • 8.2 Specialty and Dermatology Clinics
    • 8.2.1 Overview
    • 8.2.2 Specialty and Dermatology Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Hospitals and Clinics
    • 8.3.1 Overview
    • 8.3.2 Hospitals and Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Botulinum Toxin Market - Country Analysis

  • 9.1 Europe: Botulinum Toxin Market
    • 9.1.1 Europe: Botulinum Toxin Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.1 Germany
        • 9.1.1.1.1 Overview
        • 9.1.1.1.2 Germany: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.1.3 Germany: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.1.4 Germany: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.1.4.1 Germany: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.1.4.2 Germany: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.1.5 Germany: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.2 United Kingdom
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.2.3 United Kingdom: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.2.4 United Kingdom: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.2.4.1 United Kingdom: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.2.4.2 United Kingdom: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.2.5 United Kingdom: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.3 France
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 France: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.3.3 France: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.3.4 France: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.3.4.1 France: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.3.4.2 France: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.3.5 France: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.4 Italy
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 Italy: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.4.3 Italy: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.4.4 Italy: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.4.4.1 Italy: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.4.4.2 Italy: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.4.5 Italy: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.5 Spain
        • 9.1.1.5.1 Overview
        • 9.1.1.5.2 Spain: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.5.3 Spain: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.5.4 Spain: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.5.4.1 Spain: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.5.4.2 Spain: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.5.5 Spain: Botulinum Toxin Market Breakdown, by End User
      • 9.1.1.6 Rest of Europe
        • 9.1.1.6.1 Overview
        • 9.1.1.6.2 Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.1.6.3 Rest of Europe: Botulinum Toxin Market Breakdown, by Product
        • 9.1.1.6.4 Rest of Europe: Botulinum Toxin Market Breakdown, by Application
        • 9.1.1.6.4.1 Rest of Europe: Botulinum Toxin Market Breakdown, by Medical
        • 9.1.1.6.4.2 Rest of Europe: Botulinum Toxin Market Breakdown, by Aesthetic
        • 9.1.1.6.5 Rest of Europe: Botulinum Toxin Market Breakdown, by End User

10. Company Profiles

  • 10.1 Merz Pharma GmbH & Co KGaA
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 AbbVie Inc
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Ipsen SA
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Evolus Inc
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Medytox Inc
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Galderma SA
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners